ABL Bio Market Cap

ABL Bio has a market cap or net worth of 10.52 trillion as of March 6, 2026. Its market cap has increased by 452.48% in one year.

Market Cap

10.52T

Enterprise Value

10.44T

Revenue

88.44B

Ranking

n/a

PE Ratio

n/a

Stock Price

190,300.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 10.52T, an increase of 1,629.04%. That is a compound annual growth rate of 48.43%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	10.52T	-4.55%
Dec 30, 2025	11.03T	663.70%
Dec 30, 2024	1,443.63B	22.53%
Dec 28, 2023	1,178.16B	7.19%
Dec 29, 2022	1,099.13B	5.54%
Dec 30, 2021	1,041.42B	-27.59%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	76.10T
Celltrion	46.51T
ALTEOGEN	19.95T
Sam Chun Dang Pharm.	17.77T
SK Biopharmaceuticals	8,058.43B
Yuhan	7,379.93B
LigaChem Biosciences	7,251.90B
HLB Co., Ltd.	6,749.36B

Market Cap Rankings